Cure8 research brief
Why This Matters
In endemic areas, intestinal amoebiasis can coexist with or mimic ulcerative colitis flares in children, affecting treatment choices. Identifying infection may prevent inappropriate escalation of immunosuppression.
Who Should Pay Attention
Pediatric patients with UC, parents/caregivers in endemic regions, and clinicians who manage pediatric IBD.
Study Snapshot
What To Know
This article presents three pediatric case reports from an endemic region where stool microscopy identified Entamoeba histolytica in children with ulcerative colitis who presented with abdominal pain, bloody diarrhea, and in one case fever.
Initial treatment with metronidazole produced only transient improvement and two patients who were previously in remission later required escalation of immunosuppression; one child initially treated with corticosteroids elsewhere did not respond until referred.
These cases illustrate that screening for amoebiasis (stool testing) should be considered when children with UC present with suspected flare in endemic areas to help distinguish infection from immune-mediated disease activity and to guide appropriate use of antiparasitic therapy versus immunosuppression.
Keep In Mind
Small case series (three patients) reported in an abstract; useful as a clinical reminder but not definitive evidence for practice change.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.